Background Targeted therapies will be the regular treatment in patients with metastatic renal cell carcinoma (mRCC) and so are known to trigger adverse pulmonary events. halo/atoll pattern in a single (6%) case. Bottom line OP may be the main differential medical diagnosis to be looked at in sufferers with targeted therapies and pulmonary adjustments. Knowledge… Continue reading Background Targeted therapies will be the regular treatment in patients with